| Recent Press Releases | |
|
|
| Locations |
| Osteosarcoma | |
| Lymphosarcoma | |
| Hemangiosarcoma | |
| Histiocytoma | |
| Mammary Tumors | |
| Mast Cell Tumors |

PharmaCom BioVet, Inc. is quickly positioning itself to becoming the leader in specialized veterinary oncology (cancer treatment facilities for animals). PharmaCom BioVet, Inc. management is planning the rollout of specialized veterinary oncology clinics that will be strategically located throughout the United States. PharmaCom BioVet, Inc. has licensed a series of proprietary devices and compounds that will enable animals suffering from cancer greater life expectancy and decreased suffering.
PharmaCom BioVet, Inc. is dedicated to advancing the medical care industry for companion animals by establishing state-of-the-art treatment centers for lymphoma and other forms of cancer throughout the country. The purpose of these centers is to help prolong the quality of life for companion animals with cancer, and pursue the potential for complete cure. These centers will also operate under the philosophy of providing a compassionate care environment for both the animal patients and their owners.
The
human-companion animal bond is extremely strong and growing. With the
growing number of companion animals comes the growing need for comprehensive
care. PharmaCom BioVet, Inc. recognizes this demand as well as the current
the lack of adequate cancer treatment options or facilities for animal
lovers whose pets are suffering from lymphoma and other forms of cancer.
Backed by an impressive group of renowned medical specialists in this field
along with a solid business management team, PharmaCom BioVet, Inc. is
advancing an aggressive business model to establish a network of companion
animal cancer treatment centers around the country.